180 related articles for article (PubMed ID: 33864685)
1. Tofacitinib for the treatment of refractory pyoderma gangrenosum.
Orfaly VE; Kovalenko I; Tolkachjov SN; Ortega-Loayza AG; Nunley JR
Clin Exp Dermatol; 2021 Aug; 46(6):1082-1085. PubMed ID: 33864685
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib for the Treatment of Pyoderma Gangrenosum.
Kochar B; Herfarth N; Mamie C; Navarini AA; Scharl M; Herfarth HH
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):991-993. PubMed ID: 30404036
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab.
Gregory MH; Ciorba MA; Deepak P; Christophi GP
Inflamm Bowel Dis; 2019 Jun; 25(7):e87-e88. PubMed ID: 30753456
[No Abstract] [Full Text] [Related]
5. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.
Capella GL; Frigerio E; Fracchiolla C; Altomare G
Scand J Gastroenterol; 1999 Feb; 34(2):220-1. PubMed ID: 10192206
[No Abstract] [Full Text] [Related]
6. Tofacitinib in pyoderma gangrenosum - A case series.
Sathyanarayana VA; Roy D; Nagaraju B; Rao VKR
Int J Rheum Dis; 2024 Jan; 27(1):e14810. PubMed ID: 37395471
[TBL] [Abstract][Full Text] [Related]
7. Systemic pyoderma gangrenosum responding to infliximab and adalimumab.
Hubbard VG; Friedmann AC; Goldsmith P
Br J Dermatol; 2005 May; 152(5):1059-61. PubMed ID: 15888172
[TBL] [Abstract][Full Text] [Related]
8. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
Duchini G; Itin P; Arnold A
Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma Gangrenosum: A Review for the Gastroenterologist.
Plumptre I; Knabel D; Tomecki K
Inflamm Bowel Dis; 2018 Nov; 24(12):2510-2517. PubMed ID: 29788368
[TBL] [Abstract][Full Text] [Related]
10. Pustular pyoderma gangrenosum.
Shankar S; Sterling JC; Rytina E
Clin Exp Dermatol; 2003 Nov; 28(6):600-3. PubMed ID: 14616824
[TBL] [Abstract][Full Text] [Related]
11. [Pyoderma gangrenosum: report of 11 cases].
López de Maturana D; Amaro P; Aranibar L; Segovia L
Rev Med Chil; 2001 Sep; 129(9):1044-50. PubMed ID: 11725468
[TBL] [Abstract][Full Text] [Related]
12. Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient.
Salmón Olavarría P; Rubio Iturria S; Nantes Castillejo Ó
Rev Esp Enferm Dig; 2021 Oct; 113(10):733-734. PubMed ID: 33845581
[TBL] [Abstract][Full Text] [Related]
13. Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.
Piqueras-García J; Sahuquillo-Torralba AJ; Torres-Navarro I; Botella-Estrada R
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):776-778. PubMed ID: 31151671
[No Abstract] [Full Text] [Related]
14. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
Groleau PF; Grossberg AL; Gaspari AA
Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
[TBL] [Abstract][Full Text] [Related]
16. Infliximab for peristomal pyoderma gangrenosum.
Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
[TBL] [Abstract][Full Text] [Related]
17. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
[TBL] [Abstract][Full Text] [Related]
18. [Pyoderma gangrenosum: case series].
Richetta AG; Maiani E; Carboni V; Carlomagno V; Cimillo M; Mattozzi C; Calvieri S
Clin Ter; 2007; 158(4):325-9. PubMed ID: 17953284
[TBL] [Abstract][Full Text] [Related]
19. [Infliximab for a girl with refractory pyoderma gangrenosum].
Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum.
Conrad C; Trüeb RM
J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]